Paul M. Wetzel
Known title: DirectorCIK: 0001709824
Associated companies
Transaction History
| BHF | ▲ Buy | Option Exercise | 2,837 | $0 | 6/2/2026 | View on chart |
| BHF | ▲ Buy | Option Exercise | 1,120 | $0 | 5/1/2026 | View on chart |
| BHF | ▲ Buy | Option Exercise | 3,703 | $0 | 5/1/2026 | View on chart |
| BHF | ▲ Buy | Option Exercise | 1,120 | $0 | 5/1/2025 | View on chart |
| BHF | ▲ Buy | Option Exercise | 3,615 | $0 | 5/1/2024 | View on chart |
| BHF | ▲ Buy | Option Exercise | 3,454 | $0 | 5/31/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
BHF Analyst Target Cut to $57, Rating Upgrade Amid Market Attention
KBW lowered its price target for BHF to $57, while a rating upgrade is expected after a pending acquisition. The stock has attracted attention following a 24% drop and its inclusion among life‑insurance names sensitive to rising Treasury yields. These developments add context to BHF’s valuation, which sits at a trailing P/E of 3.4 and an analyst average target of $65.
BHF Analyst Target Cut to $57, Rating Upgrade Amid Market Attention. KBW lowered its price target for BHF to $57, while a rating upgrade is expected after a pending acquisition. The stock has attracted attention following a 24% drop and its inclusion among life‑insurance names sensitive to rising Treasury yields. These developments add context to BHF’s valuation, which sits at a trailing P/E of 3.4 and an analyst average target of $65.